Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3533 |
|
| Actual shortage: | 232 (7%) | |
| Anticipated shortage: | 3 (0%) | |
| Avoided shortage: | 11 (0%) | |
| Resolved: | 3287 (93%) | |
Discontinuation Reports |
366 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 342 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
32 (12%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | 850MG 50MG | TABLET | Resolved | 2024-07-05 | 2024-09-27 | 232324 |
| APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | 500MG 50MG | TABLET | Resolved | 2024-07-05 | 2024-08-09 | 232328 |
| APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | 1000MG 50MG | TABLET | Resolved | 2025-03-13 | 2025-06-06 | 252564 |
| APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | 50MG 1000MG | TABLET | Actual shortage | 2025-07-25 | 2025-12-11 | 263574 |
| APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | 50MG 1000MG | TABLET | Actual shortage | 2025-09-18 | 2025-12-11 | 267470 |
| APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | 850MG 50MG | TABLET | Actual shortage | 2025-10-03 | 2025-12-11 | 268558 |
| APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | 50MG 500MG | TABLET | Actual shortage | 2025-10-10 | 2025-12-11 | 269353 |
| APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | 500MG 50MG | TABLET | Actual shortage | 2025-12-11 | 2025-12-11 | 274185 |
| APO-SITAGLIPTIN/METFORMIN XR | 1000MG 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-12-16 | 2023-01-09 | 178772 |
| APO-SITAGLIPTIN/METFORMIN XR | 1000MG 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-12-16 | 2023-01-20 | 178775 |
| APO-SITAGLIPTIN/METFORMIN XR | 1000MG 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-03-02 | 2024-02-02 | 185967 |
| APO-SITAGLIPTIN/METFORMIN XR | 500MG 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-03-02 | 2024-02-02 | 185970 |
| APO-SITAGLIPTIN/METFORMIN XR | 1000MG 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-03-02 | 2024-02-02 | 185973 |
| APO-SITAGLIPTIN/METFORMIN XR | 1000MG 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-03-02 | 2024-02-02 | 185976 |
| APO-SITAGLIPTIN/METFORMIN XR | 1000MG 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-03-02 | 2024-02-02 | 185982 |
| APO-SITAGLIPTIN/METFORMIN XR | 1000MG 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-03-02 | 2024-02-02 | 185985 |
| APO-SITAGLIPTIN/METFORMIN XR | 1000MG 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2025-10-03 | 2025-10-16 | 268561 |
| APO-SITAGLIPTIN/METFORMIN XR | 50MG 1000MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2025-11-13 | 2025-11-27 | 271847 |
| APO-SOTALOL | 80MG | TABLET | Resolved | 2023-01-06 | 2023-02-16 | 180086 |
| APO-SOTALOL | 160MG | TABLET | Resolved | 2023-01-06 | 2023-02-16 | 180093 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-TIMOP | 0.5% | SOLUTION | Discontinued | 2019-01-03 | 2019-01-03 | 70894 |
| APO-TIMOP GEL | Discontinued | 2019-01-03 | 2019-01-03 | 71020 | ||
| APO-TIMOP | Discontinued | 2019-01-02 | 2019-01-02 | 70818 | ||
| APO-TOLTERODINE | 1MG | TABLET | Discontinued | 2018-09-08 | 2019-01-17 | 60822 |
| APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2018-11-09 | 60825 |
| APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60828 |
| APO-TRAZODONE TABLETS 100MG | 100MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60831 |
| APO-TRAZODONE TABLETS 50MG | 50MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60834 |
| APO-VALACYCLOVIR | 500MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60840 |
| APO-VALGANCICLOVIR | 450MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60843 |
| APO-VALPROIC ACID ORAL SOLUTION | 250MG | SOLUTION | Discontinued | 2023-09-26 | 2023-11-02 | 205310 |
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71029 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71032 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71035 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71038 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71044 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71048 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71051 | ||
| APO-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71054 |
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71057 |